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DATA-SHARING AND DATA-WITHHOLDING IN GENETICS
AND THE LIFE SCIENCES: RESULTS OF A NATIONAL SURVEY
OF TECHNOLOGY TRANSFER OFFICERS
ERIC G. CAMPBELL Ph.D.*
ERAN BENDAVID M.D.**
I. INTRODUCTION
Openness in data-sharing in academic research (defining data to include the
full range of research results, including materials useful for future investigation) is
regarded as a major ideal in the conduct of science. Merton described
"communism" 
-the communal sharing of data and ideas-as a fundamental norm
of the academic and scientific enterprise.' Though Mertonian norms are not
universally accepted, the importance attached to the ideal of openness is illustrated
by this quotation from Albert Einstein, which is inscribed at the base of his statue
in front of the National Academy of Sciences: "The right to search for truth implies
also a duty: one must not conceal any part of what one has recognized to be true."2
Recent evidence suggests, however, that in the daily practice of U.S.
biomedical science, the powerful ideal of openness is often breached. Anecdotally,
a number of instances of data-withholding have been reported in the press and
scientific journals.3 Additionally, a recent study of data-withholding reported that
47% of geneticists who asked other faculty for additional information, data or
materials regarding published research reported that at least one of their requests
had been denied in the preceding three years. 4 Ten percent of all post-publication
* Eric G. Campbell is an assistant professor of health policy at Harvard medical school and the Institute
for Health Policy, Massachusetts General Hospital, Boston, MA.
** Eran Bendavid is a project director at the Institute for Health Policy, Massachusetts General
Hospital, Boston, MA.
1. ROBERT MERTON, SOCIAL THEORY AND SOCIAL STRUCTURE 610 (3d ed. 1968).
2. NAT'L ACADEMY OF SCIENCES, NAS BUILDING-THE EINSTEIN MEMORIAL, at
http://www.nationalacademies.org/nas/nashome.nsf (last visited Jan. 30, 2003).
3. See, e.g., Drummond Rennie & Veronica Yank, Editorial, Disclosure to the Reader of
Institutional Review Board Approval and Informed Consent, 277 JAMA 922 (1997); Richard A. Knox,
Biomedical Results Often are Withheld: Study Examines Researchers' Financial Links to Corporations,
BOSTON GLOBE, April 16, 1997, at Al; Betty J. Dong et al., Bioequivalence of Generic and Brand-
name Levothyroxine Products in the Treatment of Hyperthyroidism, 277 JAMA 1205 (1997); Ralph T.
King, Jr., Bitter Pill: How a Drug Firm Paid for University Study, Then Undermined It, WALL ST. J.,
April 25, 1996, at Al; Jon Cohen, Share and Share Alike Isn't Always the Rule in Science, 268 SCl.
1715 (1995).
4. Eric G. Campbell et al., Data Withholding in Academic Genetics: Evidence from a National
Survey, 287 JAMA 473, 477 (2002). Much of the foregoing article is based on this research conducted
by the authors. The conclusions of the study were based on a survey of 1,849 geneticists and other life
scientists in the 100 U.S. universities that received the most funding from National Institutes of Health
(NIH) in 1998.
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requests for additional information were denied.5 Because they were denied access
to data, information or materials, 28% of geneticists reported that they had been
unable to confirm published research.6 Twelve percent said that in the previous
three years, they had denied another academician's request for data, information or
materials concerning published results. 7 Among geneticists who said they had
intentionally withheld information, data or material regarding their published work,
80% reported it required too much effort to produce the materials or information,
64% that they were protecting the ability of a graduate student, post-doctoral
fellow or junior faculty member to publish, and 53% said they were protecting
their own ability to publish.8
Such departures from the ideal of openness in science reflect the influence of
powerful societal, institutional and individual motives. Government agencies
(usually outside the life sciences) sometimes insist on secrecy in some publicly
funded research to protect national security interests. 9 In the 1980s, federal
policies also began to promote the commercialization of research through revisions
in patent law and other statutes.' 0 The purpose, to quote Abraham Lincoln's vivid
rationale for the patent system, was to "add the fuel of interest to the fire of
genius," and the result was an explosion of academic-industry relationships (AIRs)
that created individual and institutional pressures to restrict sharing of scientific
information. "1
Studies of AIRs in the life sciences reveal that universities commonly grant
industrial sponsors of research a period during which publication of results will be
delayed, so that companies can review findings and secure rights to
commercializable products. 12  Twenty percent of academic-industry research
relationships reviewed by the NIH permitted industries to delay publication for
longer than six months, and more than 80% of life science companies supporting
research in universities reported in a recent survey 13 that their agreements
5. Id.
6. Id. at 478.
7. Id. at 477.
8. Id. at 478.
9. See generally Peter M. Brody, The First Amendment, Governmental Censorship, and
Sponsored Research, 19 J.C. & U.L. 199 (1993).
10. See generally NAT'L RES. COUNCIL, INTELLECTUAL PROPERTY RIGHTS AND RES. TOOLS IN
MOLECULAR BIOLOGY (1997), available at http://www.nap.edu/readingroom/books/property (last
visited Jan. 30, 2003); see also David Blumenthal, Growing Pains for New Academic/Industry
Relationships, 13 HEALTH AFFAIRS 176 (1994) [hereinafter Blumenthal, Growing Pains].
11. Senator Abraham Lincoln, Address at the Young Men's Association of Bloomington, Illinois
(Apr. 6, 1858), available at http://showcase.netins.net/web/creative/lincoln/education/patent.htm (last
visited Mar. 5, 2003).
12. David Blumenthal et al., Relationships Between Academic Institutions and Industry in the Life
Sciences- An Industry Survey, 334 NEw ENG. J. MED. 368, 371 (1996) [hereinafter Blumenthal et al.,
Relationships Between Academic Institutions and Industry].
13. Id.
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sometimes require academic researchers to keep research results secret prior to
filing a patent. Further, work by Blumenthal, Causino, and Campbell suggests that
AIRs in genetics are both more prevalent than other fields, and more likely to
involve restrictions on open communication.'
4
Previous work has demonstrated that AIRs may affect the tendency of
academic scientists to share data with others or to withhold it in the hopes of
protecting proprietary interests.' 5 For example, when faculty patent the results of
their research, or start a new company, they are more likely not only to delay
publication of research results, but also to refuse informal requests from colleagues
for access to scientific resources.
6
Technology transfer officers (TTOs) stand at the interface of the industrial
and academic worlds and oversee the transfer of technology from the academic to
the commercial setting. In this role, TTOs observe and often participate in many
of the ethical and normative issues surrounding academic-industry relations such
as data-sharing and withholding. TTOs, for example, coordinate Materials
Transfer Agreements (MTAs), oversee regulations in agreements between industry
and academic scientists, and are responsible for the process of patenting and
commercializing findings by faculty. Recent comments, however, suggest that
TTOs are viewed as barriers to the transfer of information between academia and
industry. 17  To date, we know very little about their unique perspective and
experiences with data sharing and withholding in academic science. This study
considers the attitudes and practices of TTOs an important factor in determining
both the scope and impact of secrecy in the life sciences. Opposition to openness
from TTOs could provide a significant barrier to sharing, even with the best
intentions from academic and industrial scientists. In other words, TTOs are
significant participants in the scientific conduct today. The purpose of this study
was to shed light on the roles and views of TTOs with respect to data-sharing and
withholding in genetics and the life sciences.
14. David Blumenthal et al., Academic-Industry Research Relationships in Genetics: A Field
Apart, 16 NATURE GENETICS 104, 106 (1997) [hereinafter Blumenthal, Academic-Industry Research].
15. Campbell et al., supra note 4, at 478; see also Blumenthal et al., Relationships Between
Academic Institutions and Industry, supra note 12, at 371; David Blumenthal et al., University-Industry
Research Relationships in Biotechnology: Implications for the University, 232 SCI. 1361, 1362 (1986)
[hereinafter Blumenthal et al., University-Industry Research]; David Blumenthal et al., Participation of
Life-Science Faculty in Research Relationships with Industry, 335 NEw ENG. J. MED 1734, 1737
(1996) [hereinafter Blumenthal et al., Participation of Life-Science Faculty].
16. See Campbell et al., supra note 4, at 478.
17. Hamilton Moses III et al., Collaborating With Industry- Choices for the Academic Medical
Center, 347 NEw. ENG. J. MED. 1371, 1372 (2002).
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II. METHODS
A. Sample
The data for this paper was obtained from a mailed survey of the senior TTOs
at the 100 universities that received the most funding from the NIH in 1998.18
Using the internet and institutional directories we identified all offices of
technology transfer at each institution. When more than one office existed, we
selected the technology transfer office that provided services to the medical school
and/or the teaching hospital. We contacted each office by phone and identified the
senior TTO (usually holding the title of director) in each of the selected offices.
The design of the survey instrument was informed by ten semi-structured
interviews with knowledgeable TTOs, discussions with colleagues, and a review of
the literature. 19 Several survey items were drawn from a previous faculty survey
instrument, designed to measure the effects of data-sharing and withholding among
faculty in the life sciences.20 The survey instrument was informally pre-tested by
asking several TTOs to review and comment on the instrument.
B. Survey Administration
The study and the survey instrument were approved by the Institutional
Review Board at Massachusetts General Hospital, and the survey was administered
by mail between September and November, 2 0 0 1.21 All subjects were sent a letter,
a fact sheet describing the study, a survey instrument, a postage-paid return
envelope, and a postage-paid postcard. Subjects were asked to complete the
survey and mail the postcard separately from the completed survey. This process
enabled us to track non-respondents via the postcard while assuring respondents
complete anonymity since the survey instrument had no identifying information.
Non-respondents were mailed a letter prompting them to answer the survey, and
then were contacted by telephone and encouraged to participate. Of the potential
100 respondents, 79 valid questionnaires were received (an overall response rate of
79%).22
18. The complete list of targeted TTOs and their respective universities is on file with the authors.
19. The timetable of interviews, discussions and review of literature was conducted in 2001.
20. See Campbell et al., supra note 4, at 476.
21. NIH, DATA-SHARING AND DATA-WITHHOLDING IN GENETICS AND THE LIFE SCIENCES: NAT'L
SURVEY OF TECHNOLOGY TRANSFER OFFICERS (2001) (unpublished survey) (on file with the Journal of
Health Care Law & Policy) [hereinafter NAT'L SURVEY OF TECHNOLOGY TRANSFER OFFICERS].
22. Id.
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C. Variables
1. Measures of Office Activity
Respondents were asked to estimate the level of activity of their offices using
several measures.2 3 We asked for the number of full-time professional employees,
the total budget for the most recent fiscal year, the total revenues from research-
related payments, and the percentage of the revenues derived from activities in the
life sciences and genetics.24 Further, we measured office activity related to the life
sciences during the previous year using various outputs of technology transfer,
including the number of invention disclosures, MTAs, provisional patent
applications, patent applications, patents granted, patents licensed, confidentiality
agreements, and start-up companies. 25 Finally, we asked respondents to estimate
how office activity in genetics had changed over the past five years compared with
the rest of life sciences.26 The categories were "increased very much more,"
"increased somewhat more," "been the same," "decreased somewhat more," and
"decreased very much more."
2. Measures of Attitudes Towards Data-Sharing and Data- Withholding
Respondents were asked to rate the extent to which they agreed with the
following statements: Academic scientists should:
(a) Freely share information, data or materials with all other academic
scientists prior to publication; (b) Freely share information, data or
materials with all other academic scientists after publication; (c) Be
more cautious when sharing with industry scientists than with other
academics; (d) Be motivated only by the desire for knowledge and
discovery, not by the possibility of personal gain; (e) Keep their newest
findings secret to ensure priority in publishing; (f) Keep their newest
findings secret to ensure priority in commercial application; (g) Receive
some direct benefit (e.g., reciprocal sharing, monetary) from sharing
information, data or materials; (h) Refrain from conducting classified
research; (i) Refrain from participating in trade secrecy (defined as
information that is kept secret to protect its commercial value); ()
Limit the involvement of students and post-docs in their commercial
activities.
27
23. Id. at 1, 6.
24. Id. at 6.
25. Id. at 7.
26. Id.
27. NAT'L SURVEY OF TECHNOLOGY TRANSFER OFFICERS, supra note 21 at 5.
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The response categories were "strongly agree," "agree," ".disagree," and "strongly
disagree." For analytic purposes we grouped the "strongly agree" and "agree"
responses indicating agreement with the statement. We also grouped the
"disagree," and "strongly disagree" responses indicating disagreement.
28
3. Institutional Polices
We asked TTOs if their institutions have formal policies (including language
that should be included in all grants and contracts) which prohibit researchers from
conducting research that can never be published or publicly presented without the
consent of the sponsor.29 TTOs were also asked about the existence of policies that
prohibit researchers from sending and receiving biomaterials without an approved
MTA, policies that prohibit research agreements obligating delays of publication
beyond the time required to file a patent, and policies that require researchers to
submit an invention disclosure form to their institution prior to independently
seeking to commercialize the results of their research.3 ° When a policy existed we
asked respondents to indicate the extent to which the policy was enforced.31 The
response categories were "very strictly," "somewhat strictly," "not very strictly,"
and "not at all."32
4. Impact of Withholding on Technology Transfer
Finally, respondents were asked to estimate how often, within the last year,
the presentation or publication of research results by researchers in their institution
had resulted in the denial of a foreign patent application, the denial of a U.S. patent
application, the loss of an existing commercial partner, an inability to attract new
commercial partners, the threat of a lawsuit, or an actual lawsuit. 33 The response
categories were "never," "rarely," "often," and "very often."34  For analytic
purposes we grouped the "rarely," "often," and "very often" responses together
indicating that an event had occurred at least once in the last year.
A second set of questions asked how often, in the last year, their offices were
unable to negotiate an MTA with an academic institution, unable to negotiate an
MTA with a non-academic institution, unable to grant a license, or unable to
receive a license as a result of research sponsors' restrictions on the sharing of
information, data, or materials. 35 The response categories, again, were "never,"
28. Id.
29. Id. at 2.
30. Id.
31. Id.
32. NAT'L SURVEY OF TECHNOLOGY TRANSFER OFFICERS, supra note 21, at 2.
33. Id. at 3.
34. Id.
35. Id. at 4.
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"rarely," "often," and "very often. 36  For analytic purposes we grouped the
"rarely," "often," and "very often" responses together indicating that an event had
occurred at least once in the last year.
IV. RESULTS
A. Respondent and 77O's Office Characteristics
Table 1 shows the characteristics of the respondents. Almost three-quarters
were male, 77%, had a Master's degree, and more than one-half, 64%, had either a
doctoral or a law degree.37 On average, our respondents had been in their current
position for 4.6 years and working in the technology transfer field for nine years.
Prior to working in technology transfer, almost one-half, 45%, spent more than five
years conducting research in the life and health sciences, while one-third had no
research experience in the sciences at all.
Table 2 presents several indicators of technology transfer activity in the past
year. On average, the technology transfer offices surveyed had annual revenues of
over $5.7 million, 77% of which was from the life sciences, and 20% from
activities in genetics alone.38 Also, respondents reported receiving an average of
66 invention disclosures on which they filed provisional patent applications on 31,
and full patent applications on 35.39 On average, the technology transfer offices in
our survey were granted 22 patents, had 16.2 patents licensed, and had been
responsible for 3.4 start-up companies in the past year.40
36. Id.
37. See infra Table 1.
38. See infra Table 2.
39. See infra Table 2.
40. See infra Table 2.
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Table 1: Respondent Characteristics
N (%) Mean
Gender:
Male 57 73 na
Female 21 27 na
Degree:
Bachelor's 77 99 na
Master's 54 77 na
Doctoral or Law 49 64 na
Experience:
No research experience 26 33 na
Research experience 17 22 na
<=5 years
Research experience 35 45 na
>5 years
#Years in field 79 na 9.1
#Years in current 79 na 4.6
position
We asked respondents to estimate the relative change in technology transfer
activities in genetics compared to the rest of the life sciences.4' On every measure
of technology transfer reported in Table 1, TTOs reported a greater relative
increase in activity in genetics compared to the other life sciences in the past five
years. For example, over 71% reported a greater increase in the number of MTAs.
Similarly, 63%, 55%, and 53% reported a relative increase in patent applications,
patents granted, and patents licensed in genetics over the past five years,
respectively.42
B. Attitudes Towards Data-Sharing and Data- Withholding
The bars in Figure 1 show TTOs' attitudes towards a set of statements
regarding various aspects of the technology transfer process, data-sharing and
withholding in academic science.43 The bars to the right of the dotted line show
the percentage of respondents who agree with a statement, while the bars to the left
41. See NAT'L SURVEY OF TECHNOLOGY TRANSFER OFFICERS, supra note 21, at 7.
42. Survey response sheets and tallied responses are on file with the authors.
43. See infra Figure 1.
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of the dotted line indicate the percentage of respondents who disagree with a
statement. 44
Table 2: Characteristics of Office Activity
Full-time employees
Budget for the recent fiscal year
Total Revenues
% Revenues from life sciences
% Revenues from genetics
Invention disclosures
Material transfer agreements
Provisional patent applications
Patent applications
Patents granted
Patents licensed
Confidentiality agreement
Start-up company
Mean
5.1
$1,200,410.00
$5,792,700.00
77.0
19.8
65.9
194.4
30.7
34.9
22.2
16.2
88.2
3.4
&
Figure 1: Attitudes
Disagree Agree
Freely share information with all
academic scientists prior to publication
Freely share information with all
academic scientists after publication
Be more cautious when sharing with
industry than with other academics
Keep findings secret to ensure priority in
publishing
Keep findings secret to ensure priority in
commercial applications
Receive some direct benefit from
sharing information
Refrain from conducting classified
research
Refrain from participating in trade
secrecy
5 3
-49
44. See supra Figure 1.
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Among TTOs there is almost unanimous agreement, 98.7%, that academic
scientists should freely share data and information with other academic scientists
after publication.45 However, there is significant disagreement that such openness
of sharing with other academic scientists should occur prior to publication: 30.5%
agree and 69.5% disagree that scientists should share data and materials prior to
publication.46  Furthermore, about three-quarters, 77%, agree that academic
scientists should be more cautious when sharing research information, data, and
materials with industry scientists than with other academics, and two-thirds, 67%,
of TTOs felt that academic scientists should receive something in return for
sharing scientific resources.4 7
Respondents lacked consensus in their attitudes towards the other statements.
There was a trend towards agreement with the statement that scientists should keep
findings secret to ensure priority in publishing.48 There was less agreement with
respect to commercial activities: roughly one-half of respondents agree that
scientists should keep new findings secret to ensure priority in commercial
application. 49 Similarly, about one-half thought that academic scientists should not
refrain from conducting classified research or participate in trade secrets.5 °
C. Institutional Policies and Policy Enforcement
As shown in Table 3, almost all respondents, 93%, reported that their
institution had a formal policy that required investigators to file an invention
disclosure prior to independently seeking to commercialize their research results.5'
Almost three-quarters of respondents, 72%, said their institution prohibited
research from being conducted that cannot be published without the consent of the
research sponsor.5 2 About one-half of respondents claimed their institutions have
policies that prohibit the receipt or sending of biomaterials (cell lines, tissue,
sequences, reagents, etc.) to other scientists without a MTA.53 A similar
percentage, 47%, reported a policy that prohibited research agreements that
delayed publication of research results beyond the time needed to file a patent.
54
45. Id.
46. Id.
47. Id.
48. Id..
49. Id.
50. See supra Figure 1.
51. See infra Table 3.
52. Id..
53. Id.
54. Id.
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Table_3:_InstitutionalPolicies 
_____________________
Does institution have policy to prohibit
research that can never be published without
sponsor consent?
Does institution have policy to prohibit
receipt of biomaterials from other scientists
without a MTA?
Does institution have policy to prohibit
sending biomaterials to scientists without a
MTA?
Does institution have policy to prohibit
agreements that delay publications beyond
time needed to file a patent?
Does institution have a policy to require
invention disclosure prior to seeking
independent commercialization?
Do any formal policies apply only to
research in genetics?
%Yes
72
% Enforced
Very or
somewhat strictly
98
% Enforced
Not very or not
at all strictly
2
We also asked if any of the above policies applied only to genetics.55 In no
case did respondents indicate that these or other institutional policies applied solely
to data-sharing and withholding in genetics based research.
56
All TTOs who reported that their institution had a policy that prohibited
research agreements that delayed publication beyond the time needed to file a
patent also indicated that this policy was strictly enforced.57 Similarly, 98%
reported strict enforcement of policies that prohibited faculty from conducting
research that could never be published without the consent of the research
sponsor. 58  Policies that required a MTA with the sending and receiving of
biomaterials were less strictly enforced.59
55. See supra Table 3.
56. Id.
57. Id.
58. Id.
59. Id.
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D. Negative Impact of Data-sharing and Data-withholding on the
Technology TransferProcess
We asked the respondents to indicate if their institution had experienced a
negative impact of publication on various aspects of the technology transfer
process in the last year.60 Virtually all respondents, 94%, indicated that they had
had a foreign patent application denied because research outcomes were already
published.61 Slightly fewer, 82%, reported denial of a U.S. patent application for
the same reason.62 Seventy-one percent reported that they were unable to attract a
commercial partner and one-half had lost an existing commercial partner because
research outcomes were shared with the academic community via publication.
63
Also, 32% reported being threatened with a lawsuit as a result of publication, while
13% reported an actual lawsuit had occurred within the last year.64
Table 4: Negative Impact
Experienced
Impact at Least Once
(O) (N)
In the past year, how often has the publication
of research outcomes resulted in:
Denial of foreign patent application 94 74
Denial of US patent application 82 65
Loss of existing commercial partner 50 39
Inability to attract new partner 71 55
Threat of a lawsuit 32 25
Actual lawsuit 13 10
In the past year, how often have sponsors'
restrictions on data sharing resulted in:
Failure to negotiate an MTA with another academic institution 46 36
Failure to negotiate an MTA with a non-academic institution 85 66
Failure to grant a license 48 38
Failure to receive a license 27 21
60. See NAT'L SURVEY OF TECHNOLOGY TRANSFER OFFICERS, supra note 21, at 3.
61. See supra Table 4.
62. Id.
63. Id.
64. Id.
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We also asked about the negative impact of research sponsors' restrictions
on the sharing of information, data and materials on technology transfer.65 Forty
six percent and 85%, respectively, indicated that sponsors' restrictions resulted in
an inability to negotiate a MTA with another academic institution and another non-
academic institution.6 6 About one-half of respondents, or 48%, reported their
institution was unable to grant a license to a company as a result of the research
sponsors' restrictions on data-sharing and withholding.67
V. DIscusSION
The data presented above represent the first systematic study of the attitudes
and policies governing TTOs, especially from offices serving medical schools and
hospitals. Several of the results presented above warrant discussion.
First, TTOs' attitudes towards data-sharing and withholding both before and
after publication overwhelmingly support current practices in academic science in
which periods of data-withholding are legitimized in order to ensure priority in
publication- the primary mechanism by which scientists secure credit for their
work and the coin of the realm of the reward system of academic science.68
However, once published it is generally believed that scientific information, data,
and materials included in the publication should be openly shared in the scientific
community. This demonstrates that TTOs have been enculturated to academic
scientific practices, which is not surprising since almost one-half of respondents
had spent more than five years conducting research in the life sciences prior to
serving as a TTO.69
Secondly, it is clear that the vast majority of TTOs believe academic
scientists should be more careful when sharing research related information, data
and materials with industry than with other academics. 70  Although we do not
know the exact reasons for this concern, given that TTOs have considerable
experience dealing with industry, it may be advisable for faculty to heed their
advice when sharing research-related information, data and materials.
It is also interesting to note the lack of consensus in several attitudes towards
data-sharing and withholding. Of the eight statements gauging TTO attitudes, four
lack consensus (that is, there was no significant difference between the groups that
agreed and disagreed with the statements). This reflects some of the conflicting
pressures that shape the attitudes of TTOs. While the responses to some
65. See NAT'L SURVEY OF TECHNOLOGY TRANSFER OFFICERS, supra note 2 1, at 4.
66. See supra Table 4.
67. Id.
68. MARY FRANK FOX, Publication Performance, and Reward in Science, in HIGHER EDU.
HANDBOOK OF THEORY AND RES. VOL. I (John C. Stuart, ed. 1985).
69. See supra Table 1.
70. See supra Figure 1.
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statements show how TTOs have been enculturated to academic practices, attitudes
towards other statements reflect concerns with facilitating technology transfer and
commercialization of research. For example, respondents were evenly split when
asked if academic scientists should be involved in classified research or trade
secrets.71  Some of these conflicting pressures described by TTOs reflect
university-wide uncertainty with respect to secrecy.
Third, based on the reports of TTOs, some universities do not have policies
designed to limit the amount of secrecy in academic science. Recall that under
three-quarters of respondents, 72%, said their institution prohibited research from
being conducted that cannot be published without the consent of the research
sponsor, and less than half, 47%, reported a policy that prohibited research
agreements that delayed publication of research results beyond the time needed to
file a patent. 72 That is, over one-quarter of universities studied have no policies
that limit research that can never be published or that may be delayed by a sponsor
for long periods of time. These policies, when they exist, regulate secret academic
conduct and may assist scientists that are facing the challenges of funding at the
expense of open scientific behavior. And the absence of these policies suggest
there maybe significant foom for improvement in regulating data-withholding.
However, additional research is needed to better understand the extent to which
faculty are aware of, and obey, these policies, and what impact, if any, they have
on the actual behavior of academic scientists.
Finally, our study suggests that data-sharing via publications has marked
negative effects on the technology transfer activities of universities. For example,
in the last year 50% of respondents reported that their institution had lost an
existing commercial partner as a result of the publication of research outcomes.
7 3
Further, 12.7% reported that a publication by university researchers resulted in an
actual lawsuit, which may be both costly and harmful to the public image of a
university.
74
Our study also illustrates some of the implications of data-sharing and
withholding on research in genetics. As the results from the survey suggest, on
virtually every measure of technology transfer (e.g., invention disclosures, patent
applications, patents granted and licensees), the majority of respondents felt
technology transfer activities had increased more in the field of genetics than in the
other life sciences. 75 This suggests that TTOs increasingly confront data-
withholding related to genetic research as a consequence of the recent rapid
increase in commercial activity in genetics. As other published results in the field
71. See supra Figure 1.
72. See supra Table 3.
73. See supra Table 4.
74. Id.
75. Survey response sheets and tallied responses are on file with the authors.
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suggests, genetics warrant special attention with respect to secrecy and data-
withholding behavior.
76
VI. STUDY LIMITATIONS
This study has several limitations that should be kept in mind. Like all
survey data, ours is subject to biases resulting from non-response and under-
reporting of behaviors that may be viewed as negative by respondents and their
peers. Second, our survey was focused on research intensive universities and on
the biomedical sciences. Data-sharing and withholding behaviors may display
different prevalence and be influenced by different factors in less research-
intensive environments and in different fields of investigation.
Despite this limitation, our study elucidates the significance and impact of
data-sharing and withholding on the field of technology transfer. We have
illustrated some of the conflicting attitudes, negative impacts, and policies that are
driven by pressures from researchers, academic institutions and industry.
Additional research can further clarify the negative impacts of publishing and
sponsors' restrictions on technology transfer, and future policies should address
those areas where current practices and attitudes thwart the progress and work of
the technology transfer field.
76. Campbell et al., supra note 4, at 478.
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